[DOI] [PubMed] [Google Scholar] 76.Vargas AJ, Burd R
In preclinical studies, BPC-157 has shown to have a positive impact when treating conditions such as inflammatory bowel disease, traumatic brain injury, and arthritis [5]
As we indicated in the CY 2026 OPPS/ASC proposed rule, we believe the benefits to users of the MRF of having this additional information would justify the initial one-time burden to hospitals to update their processes and systems to identify and collect the newly proposed data elements and encode the standard charge information for the newly proposed data elements in the CMS standard template
Cochrane Database Syst Reviews 2019(3)
Its ability to enhance cellular health and combat oxidative stress makes it appealing for various demographics
Also known as: Bpc-157, 137525-51-0, Bpc 157, Bepecin, Bpc 15, Pl-10 Molecular Formula C 62 H 98 N 16 O 22 Molecular Weight 1419.5 g/mol InChI Key HEEWEZGQMLZMFE-RKGINYAYSA-N Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial)
